Let the shortage of medicines not be in short supply! The latest publications of the four departments

　　China News Service, August 10. Recently, four departments including the Ministry of Industry and Information Technology and the National Health and Health Commission jointly issued a notice to deploy and strengthen the monitoring of the production and reserve of drugs in shortage and the centralized procurement of drugs organized by the state.

what does that mean?

Will there be shortages of medicines in the future?

Photo by Zhang Tianfu, a reporter from the News Agency in the data map

What is a shortage of medicines?

　　In 2020, the "Notice on Printing and Distributing the National Drug Shortage List" issued by 12 departments including the National Health and Health Commission, the National Development and Reform Commission, and the Ministry of Industry and Information Technology shows that there are 6 varieties of the national drug shortage list, focusing on solving the problem of shortages on the production and supply side and ensuring the protection of drugs. supply.

　　In addition, the National Key Monitoring List of Clinically Necessary and Shortaged Drugs has a total of 57 varieties, focusing on drugs that are clinically necessary, irreplaceable or irreplaceable, and at risk of supply shortage. Through monitoring, we can grasp the supply and use of drugs, give early warning, and take timely measures. , to prevent shortages.

　　It is worth noting that dynamic adjustments have been implemented in the catalogue of drug shortage monitoring varieties and the catalogue of monitored enterprises.

　　The four-department notice also pointed out that in terms of monitoring varieties, the National Health and Health Commission announced the National Shortage Drug List, the National Clinically Necessary Drugs in Shortage Key Monitoring List, and the National Organization of Drugs Centralized procurement of selected drugs announced by the National Medical Insurance Administration.

.

Screenshot of the "Monitoring Varieties of Shortaged Drugs and Manufacturing Enterprises (Preparations)" in the notice.

What have you done over the years to keep the shortage of medicines from being in short supply?

　　In fact, in order to ensure the supply and production of drugs in short supply, many departments have introduced relevant measures in recent years.

　　In 2021, the General Office of the State Council will issue the "14th Five-Year Plan for National Medical Insurance".

Among them, it is proposed to improve the monitoring, early warning and graded response system for drugs in shortage, strengthen the enforcement of illegal acts such as monopoly of raw materials, and further ensure the supply and price of drugs in shortage.

　　The plan is clear, and the emergency reserve, inventory and production capacity reporting system for the winning production enterprises will be gradually established to ensure the supply of centralized procurement of drugs.

Support the chain, professional, and digital development of pharmacies, and give better play to the unique advantages of pharmacies and the role of pharmacists.

Relying on the national unified medical security information platform, it supports the circulation of electronic prescriptions.

Screenshot of "Selected Drugs and Manufacturers in Centralized Drug Procurement organized by the State".

　　In November 2021, the State Food and Drug Administration developed and constructed the information collection module for the production supply and discontinuation report of shortage drugs in the drug information collection platform.

　　In January of this year, the "14th Five-Year Plan for the Development of the Pharmaceutical Industry" jointly issued by the Ministry of Industry and Information Technology, the National Development and Reform Commission and other nine departments proposed to enhance the supply guarantee capacity of drugs that are prone to shortage.

, improve the purchase and payment policies for medicines that are easily in short supply, and include eligible varieties into online purchases in a timely manner to mobilize the enthusiasm of enterprises for production.

Dynamically adjust the national list of drugs in short supply and the key monitoring list of clinically necessary drugs that

.

Support the development of a drug supply guarantee consortium, expand the coverage of small-variety drugs (drugs in short supply) centralized production bases, deepen supply chain collaboration, and promote the integrated development of key varieties of APIs and preparations.

Data map Photo by Guo Jia

These situations may be interviewed and rectified in the future

　　In addition to the above measures, how to monitor the shortage of medicines in a timely manner has recently been answered.

　　On August 9, the website of the Ministry of Industry and Information Technology published the notice of the four departments on strengthening the monitoring of the production and reserve of drugs in shortage and the centralized procurement of drugs organized by the state.

　　Among them, it is required to give full play to the role of the linkage mechanism of provincial consultations, to further strengthen information communication and sharing, to strengthen monitoring and early warning, to improve the management measures for grading and responding to shortage of drugs, to guide and supervise enterprises to fulfill their information reporting obligations, and to continuously improve the ability to guarantee drug production and supply. Meet the health needs of the people.

Announcement of key shortage drug reserve enterprises

　　The notice clarifies that, before the 10th of each month, enterprises that produce drugs in shortage and those that are selected for centralized procurement shall, through the "Monitoring and Early Warning Platform for Production and Supply of Shortaged Drugs", fill in the "Monitoring Report on Production and Supply of Shortaged Drugs in Pharmaceutical Industry Enterprises" and "National Centralized Procurement of Drug Production" respectively. Supply Monitoring Report"; key drug reserve enterprises in shortage fill in the "Statistical Table of Inventory Quantity of Shortage Drugs" through the "National Medical Reserve Management Information System".

　　The notice requires that manufacturers of drugs in shortage and selected drugs in centralized procurement are the first responsible for reporting production and reserve monitoring information, and should establish and improve the monitoring information submission work system; designate a person to fill in the production and reserve data in a true, accurate, complete and timely manner. Late reporting or refusal to report; cooperate with relevant departments in the investigation of drug shortage incidents, and provide the information required for the investigation; set up production and supply inventory safety warning lines and prepare response plans.

　　The notice also calls for strengthening supervision and management.

The local industry and information technology department, together with the relevant departments, is responsible for the production and reserve monitoring of the drugs in shortage and the selected drugs in the centralized procurement in the region, organizes enterprises to submit relevant data, audits the integrity and accuracy of the data, and strengthens the supervision and inspection of drug quality. Supervise and urge production enterprises to implement their responsibilities for sufficient supply and production suspension reporting in accordance with the purchase agreement.

For enterprises that fail to comply with the requirements, they will be interviewed and required to rectify within a time limit as the case may be.

(Zhongxin Finance)

　　search

copy